MichaelThomasChinMD

Dean, Tufts Graduate School of Biomedical Sciences, Professor of Medicine, Director, MSTP Program, Research Director, Tufts Hypertrophic Cardiomyopathy Center and Research Institute

Join to view full profile

Dr. Chin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Chin's full profile

Already have an account?

Office
800 Washington St
Boston, MA 02111
Phone+1 617-636-8066

Fax+1 617-636-7175

Education & Training

Brigham and Women's HospitalFellowship, Cardiovascular Disease, 1994 - 1997
Johns Hopkins UniversityResidency, Internal Medicine, 1991 - 1993
University of Rochester School of Medicine and DentistryClass of 1991

Certifications & Licensure

MA State Medical License 1994 - 2026
NH State Medical License 2024 - 2024
ME State Medical License 2020 - 2021
WA State Medical License 2006 - 2019
MD State Medical License 1993 - 1994

Publications & Presentations

PubMed

A Barth Syndrome Patient-DerivedPoint Mutation inDrives Progressive Cardiomyopathy in Mice.
Paige L Snider, Elizabeth A Sierra Potchanant, Zejin Sun, Donna M Edwards, Ka-Kui Chan
International Journal of Molecular Sciences. 2024-07-27
2 citations
Relationship Between Genotype Status and Clinical Outcome in Hypertrophic Cardiomyopathy.
Jiri Bonaventura, Ethan J Rowin, Raymond H Chan, Michael T Chin, Veronika Puchnerova
Journal of the American Heart Association. 2024-05-21
3 citations
Novel Role for Cardiolipin as a Target of Therapy to Mitigate Myocardial Injury Caused by Venoarterial Extracorporeal Membrane Oxygenation.
Lija Swain, Shreyas Bhave, Xiaoying Qiao, Lara Reyelt, Kay D Everett
Circulation. 2024-04-23

Grant Support

Project 4: Myocardial Inury And Apoptosis With DE ExposureNational Institute Of Environmental Health Sciences2008–2011
Role Of Chf1/Hey2 In Hypertrophy And Heart FailureNational Heart, Lung, And Blood Institute2006–2009
Role Of Chf1 In Occlusive Vascular DiseaseNational Heart, Lung, And Blood Institute2006–2008
Role Of Chf1/Hey2 In Hypertrophy And Heart FailureNational Heart, Lung, And Blood Institute2006
Role Of Chf1 In Occlusive Vascular DiseaseNational Heart, Lung, And Blood Institute2005–2006
Role Of Chf1 In Cardiovascular DevelopmentNational Heart, Lung, And Blood Institute2001–2004
HMG-I Y And ArteriosclerosisNational Heart, Lung, And Blood Institute1999–2001
HMG-I Y And ArteriosclerosisNational Heart, Lung, And Blood Institute1997–1998